Behavior and inhibitory control in children with prenatal exposure to antidepressants and medically untreated

Tone Kristine Hermansen1, Espen Røysamb2,3, Else-Marie Augusti2

  • 1The Cognitive Developmental Research Unit, Department of Psychology, University of Oslo, Forskningsveien 3a, 0373, Oslo, Norway. t.k.hermansen@psykologi.uio.no.

Psychopharmacology
|March 1, 2016
PubMed

Insights

Prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) or untreated depression in mothers did not affect child cognition. However, both exposures were linked to increased behavioral problems in children.

Area of Science:

  • Child development
  • Neuroscience
  • Psychiatry

Background:

  • Maternal depression is a significant concern during pregnancy.
  • Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed for depression.
  • Understanding the impact of prenatal exposure to SSRIs and maternal depression on child development is crucial.

Purpose of the Study:

  • To investigate child development outcomes after prenatal exposure to maternal SSRI use, untreated depression, or no exposure.
  • To compare cognitive abilities and behavioral problems in 5-6-year-old children across these exposure groups.

Main Methods:

  • Cognitive abilities assessed using Wechsler Preschool and Primary Scale of Intelligence-Revised (WPPSI-r), NEPSY-II, and Attention Network Test.
  • Child behavioral problems evaluated via maternal reports using the Child Behavior Checklist (CBCL).
  • Comparative analysis using analyses of variance (ANOVA).

Main Results:

  • No significant differences in general cognition or inhibition were found between groups.
  • Prenatal exposure to both SSRIs and maternal depression was associated with increased externalizing behavioral problems.
  • Prenatal SSRI exposure was also linked to increased internalizing behavioral problems.

Conclusions:

  • Prenatal exposure to maternal depression or SSRIs does not appear to impact general cognition or inhibition in children by age 5-6.
  • Both SSRI and depression exposure are associated with negative behavioral outcomes, specifically externalizing problems.
  • SSRI exposure shows an additional association with internalizing problems, suggesting complex developmental effects.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.3K
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.9K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
843